Clinical Roundup Cancer stage and receptor status indicate risk of breast cancer recurrence March 10, 2023Vol.49 No.10
Clinical Roundup Community engagement can help improve clinical trial diversity March 10, 2023Vol.49 No.10
Clinical Roundup Immunotherapy costs drive increase in Medicare spending for outpatient cancer care at the end of life March 03, 2023Vol.49 No.09
Clinical Roundup Rutgers study: Expanded use of a personalized remote risk communication intervention increased uptake of genetic counseling March 03, 2023Vol.49 No.09
Clinical Roundup Protein partnership may fend off pancreatic cancer progression March 03, 2023Vol.49 No.09
Clinical Roundup Clinical AI enables early disease detection and proactive care for lower GI cancers, diabetes, prediabetes March 03, 2023Vol.49 No.09
Clinical Roundup Research finds ECOG scores restrict patient access to trials, preventing trials from accurately representing real-world patients February 24, 2023Vol.49 No.08
Clinical Roundup Phase III SIERRA trial has positive full data results in active, relapsed or refractory AML February 24, 2023Vol.49 No.08
Clinical Roundup Keytruda + chemo improved OS in HER2-negative gastric or GEJ cancer regardless of PD-L1 expression February 24, 2023Vol.49 No.08
Clinical Roundup Takeda presents phase III PhALLCON trial data at ASCO Plenary Series Program February 17, 2023Vol.49 No.07
